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Introduction: Effects of pulmonary rehabilitation (PR) in chronic obstructive pulmonary 
disease (COPD) patients with severely impaired health status are poorly documented since these 
patients are usually excluded from clinical trials. This retrospective, observational study aims 
to study the impact of disease on health status and the effects of PR on COPD patients referred 
to a tertiary center for PR in The Netherlands.
Methods: Between June 2006 and June 2010, 437 patients with COPD were allocated to our 
intensive, comprehensive PR program. Patients participated in this interdisciplinary program 
for 12 weeks for a weekly average of 20–25 hours. Before and directly after, several measures 
of physical performance and health-related quality of life were determined.
Results: At baseline, most patients (75%) had a Global Initiative for Chronic Obstructive 
Lung Disease (GOLD) stage of III−IV . Peak exercise performance on a cycle ergometer was on 
average reduced to 43 ± 29 Watt, and health-related quality of life was significantly impaired, 
with a total score on the St George’s Respiratory Questionnaire (SGRQ) of 66. Health-care 
utilization in the year preceding PR was very high. After rehabilitation, all outcome measures 
improved statistically significantly (P , 0.001). Exercise performance measured with the 
6 minute walking distance test improved clinically significantly in 68% of the patients, whereas 
75% of the patients showed a clinically meaningful improvement in quality of life as measured 
with the SGRQ. Multiple regression analysis revealed that 19% of the variation in responses on 
the 6 minute walking distance test and the SGRQ could be explained on the basis of baseline 
characteristics.
Conclusion: The present study provides data to indicate that COPD patients may   substantially 
benefit from rehabilitation in a tertiary pulmonary rehabilitation center, despite a severely impaired 
health status and high level of health-care utilization, in which prior treatment in   primary and 
secondary care have failed to improve health status. Individual rehabilitation responses can only 
partially be predicted on the basis of baseline characteristics. Consequently, no firm conclusions 
can be drawn from this study with respect to the selection of candidates that could be deemed 
eligible for this rehabilitation program when entering the program.
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Introduction
Chronic obstructive pulmonary disease (COPD) is clinically characterized by 
breathlessness on exertion and exercise intolerance, both of which not only interfere 
with the ability to perform the activities of daily life1 but also significantly impede 
  quality of life.2 Treatment of COPD has focused traditionally on pharmacological 
improvement of the airway obstruction. Growing evidence of extrapulmonary 
manifestations in patients with COPD and their consequences for the functioning International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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of these patients has accelerated the development and use 
of non-pharmacological interventions like pulmonary 
rehabilitation (PR). PR has been shown now to be the most 
effective non-pharmacological intervention to improve health 
status in COPD patients.3 The efficacy of PR in improving 
symptoms, exercise tolerance, and health-related quality of 
life (HRQL) has been demonstrated by meta-analyses4.5 and 
is recommended in several influential guidelines.6,7
In The Netherlands, PR is offered to patients with COPD 
in a continuum of care, with care being given in private 
physiotherapy practices, in outpatient clinics of hospitals, 
and in specialized, tertiary referral centers, formerly 
tuberculosis sanatoria. In the latter, patients receive a 
comprehensive rehabilitation program on either an inpatient 
or outpatient basis by an interdisciplinary team of health-
care professionals. Because of the “last resort function” of 
these tertiary referral centers, it has become current practice 
to refer patients with a severely impaired health status.8 
In many patients, prior treatment, including primary care and 
hospital-based rehabilitation, had failed to improve health 
status to a satisfactory level, resulting in a persistently high 
level of care utilization. These complex patients are often 
excluded from randomized controlled clinical trials (RCTs). 
Therefore, research findings may not be applicable to these 
severely impaired COPD patients.9 In support of this concern, 
a recent review by Bjoernshave et al (2010) concluded that 
most research evaluating the effects of PR did not include 
study populations that are sufficiently representative of the 
COPD target population.10
The objectives of the present study were threefold: (1) to 
evaluate the impact of the disease on different dimensions 
of health status including health-care utilization in patients 
with COPD receiving PR in our tertiary referral center; 
(2) to compare health status measurements prior to and after 
completion of an intensive, comprehensive interdisciplinary 
rehabilitation program; and (3) to explore determinants 
that might predict change in health status following this 
rehabilitation program.
Materials and methods
Patients
All  patients  with  COPD  who  participated  in  the 
  comprehensive program of “Schoondonck” Center for 
Pulmonary Rehabilitation, Breda, The Netherlands 
between June 2006 and June 2010 were included in this 
study. Patients were referred by pulmonologists from the 
southwest region of The Netherlands to this tertiary referral 
center for PR. Reasons for referral were a high impact of 
the disease on health status, with no satisfactory response 
to prior medical and non-medical treatment, including reha-
bilitation in primary care and hospital-based rehabilitation. 
The patients who were referred and enrolled typically had 
at least three of the following features: (1) severe to very 
severe airway obstruction (Global Initiative for Chronic 
Obstructive Lung Disease [GOLD] stage of III−IV); 
(2) a markedly limited exercise performance with a maximal 
power output on a cycle ergometer (Wmax) of less than 50% 
predicted; (3) a severely impaired quality of life defined 
as a St George’s Respiratory Questionnaire (SGRQ) total 
score of more than 50, and, (4) a relatively high annual, self-
reported, exacerbation rate (more than three in the preced-
ing year) and markedly high health-care utilization (more 
than two pulmonary disease-related hospitalizations in the 
preceding year). Having stopped smoking completely by 
the start of the program was a prerequisite to participation. 
Contraindications for participation in the program included 
severe cognitive disorders resulting in the inability to learn, 
personality disorders that might interfere with participation 
in a group program, active psychiatric disorders, inability 
to communicate, and unstable cardiac or musculoskeletal 
disease that might interfere with exercise training. Persistent 
smoking, drug abuse, or legal procedures related to health 
and potentially interfering with the goals of rehabilitation 
were also considered to be contraindications.
study design
The study was a retrospective, observational study of patients 
enrolled in a comprehensive PR in a tertiary referral center 
in The Netherlands. The study was institutional review board 
exempt because all procedures and measurements were part 
of the usual care provided in our institute, and due to the use 
of de-identified, pre-existing data.
The pulmonary rehabilitation program
Pre-rehabilitation assessment
A multidisciplinary assessment is an integral part of the 
PR program. The aim of this assessment is to determine 
if intensive, comprehensive PR in our tertiary care center 
is indicated. The indication is based on an evaluation of 
the impact of the chronic respiratory disorder on different 
dimensions of health status, that is, physiological functioning, 
symptoms, activities, quality of life, and health-care 
utilization.11 Moreover, the motivation, commitment, and 
suitability for participation in an intensive rehabilitation 
program are evaluated. Finally, individual rehabilitation 
objectives are set out during the assessment.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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All assessment components are carried out during a 
5 day period by a multidisciplinary team consisting of an 
art therapist, dietician, exercise therapist, physiotherapist, 
psychologist, pulmonary technician, pulmonary physician, 
respiratory nurse, occupational therapist, and social worker. 
The International Classification of Functioning serves as 
a framework for the assessment which usually takes place 
3−4 weeks prior to the interventional phase of the program.12 
The measurement instruments are consistent with markers 
that have previously been identified as appropriate for 
measuring clinically relevant outcomes in COPD.13
Pulmonary function parameters were obtained by 
measuring spirometry, static lung volumes (body box), 
and single-breath carbon monoxide diffusion capacity 
(Masterlab, Jaeger, Würzburg, Germany) according to the 
American Thoracic Society and the European Respiratory 
Society guidelines, and were related to reference equations 
produced by the European Community of Coal and Steel.14−17 
An incremental exercise test was performed to evaluate maxi-
mal power output (Wmax) and peak oxygen uptake (VO2peak) 
(Oxycon Pro™, Jaeger, Würzburg, Germany), according 
to the European Respiratory Society recommendations on 
the use of exercise testing in clinical practice.18 Blood gases 
were obtained from capillary blood samples drawn from the 
earlobe at rest, at the end of the reference phase, at 3 minute 
intervals during exercise, at peak exercise, and after 3 and 
6 minutes of recovery. Medical Research Council (MRC) 
scores for dyspnea were recorded and the body-mass index, 
airflow obstruction, dyspnea, and exercise capacity (BODE) 
index was calculated.19,20 Exacerbation type and frequency 
in the year preceding participation in the rehabilitation were 
recorded. An exacerbation was defined as an increase in or 
new onset of more than one symptom of COPD (cough, 
sputum, wheezing, dyspnea, or chest tightness), with at least 
one symptom lasting 3 days or more and leading the patient’s 
doctor to initiate treatment with systemic glucocorticoids, 
antibiotics, or both.
Interdisciplinary rehabilitation
The program was carried out in a fixed group of eight to 
ten patients in concordance with the recommendations of 
current international guidelines on PR, and carried out by 
the same disciplines as those involved in the assessment.6 
One week before the program started, patients attended a 
2 hour group session in which they had their first face-to-
face contact with each other and with the case manager, that 
is, a therapist or nurse acting as the first contact person of 
the interdisciplinary team. This session served to provide a 
further exploration of the concept of rehabilitation, that is, the 
promotion of physical functioning as well as better adaptation 
to the chronic illness. Patients participated in the program 
5 days per week, for a weekly average of 20−25 hours on 
either an inpatient or outpatient basis. Inpatient rehabilitation 
was indicated if (1) the travel distance to the center was pro-
hibitive in light of the severity of disability; (2) a temporary 
removal from the social system was indicated in order to 
facilitate rehabilitation results, or (3) symptom evaluation 
required 24 hour observation. All of the program components 
are shown in the Appendix. Patients received interventions 
on an individual basis in addition to the group sessions, for 
example, counseling by a psychologist or social worker, 
art therapy sessions, or educational conversations with 
a dietician or respiratory nurse. The health-care professionals 
determined the indications for individual therapy sessions 
during the assessment week.
Outcome measurements
Peripheral muscle performance
Maximal isometric muscle force of the knee extensors of the 
dominant leg was measured using a handheld dynamometer 
(MicroFET2™, Biometrics, Almere, The Netherlands). 
Reference values for healthy elderly subjects established by 
Andrews et al were used.21
Respiratory muscle performance
Maximal inspiratory mouth pressure (PImax) at residual 
volume was measured using a handheld respiratory pressure 
meter (MicroRPM, Micro Medical Ltd, Rochester, UK). 
The highest of at least five maneuvers was used.22 Reference 
values of Black and Hyatt were deemed the most appropriate 
for our laboratory.23
exercise performance
Cycle exercise endurance was determined with a constant 
work-rate test on a cycle ergometer (Ergoselect 1000, 
Ergoline, Bitz, Germany) at a work rate equal to 75% of 
Wmax obtained in a preceding incremental test. This test 
has both good reliability and validity.24 An improvement 
of 100−200 seconds in cycle endurance has recently been 
suggested as the minimal clinically important difference 
(MCID).25
The 6 minute walking distance test (6MWDT) measured 
in a 40 meter corridor in accordance with the American 
Thoracic Society guidelines.26 At baseline, three tests were 
performed on alternate days. The results of the third test were 
used in the analysis. The reference values of Troosters et al International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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were used.27 A difference of 26 meters has been proposed to 
represent the MCID on this test.28
Quality of life
The Chronic Respiratory disease questionnaire (CRQ) is a 
20-item semi-structured interview that measures HRQL in 
four domains: dyspnea (five items), fatigue (four items), 
emotions (seven items), and mastery (four items). In addition, 
a total score can be calculated.29 The five questions comprising 
the dyspnea domain are unique to the respondent. For these, 
the patient must identify five activities that they undertook 
frequently and that had produced dyspnea in the past 2 weeks. 
Each of the five chosen activities is then scored using a 7-point 
Likert scale; from 1 (extremely short of breath) to 7 (not at all 
short of breath). The remaining 15 questions encompassing 
the three other domains are also scored using a 7-point 
scoring system. Higher scores indicate less impairment in 
HRQL. A change of 0.5 unit per question resulting from an 
intervention is considered to be clinically meaningful.30
The St George’s Respiratory Questionnaire (SGRQ) is a 
76-item disease-specific questionnaire. It measures HRQL 
in three domains: symptoms (distress due to respiratory 
symptoms), activities (the effects due to impairment of 
mobility or physical activity), and impacts (the psychoso-
cial impact of the disease), plus a summary total score.31 
Each item is weighted using empirically derived weights. In 
addition, a summary score can be calculated. Scores range 
from 0 (no impairment) to 100 (maximal impairment) for 
each subscale and for the total score. Lower scores indicate 
better health status, and a change of 4 points in total score 
(out of 100) is considered clinically meaningful.32
The Medical Outcomes Study Short-Form   Survey, version 
2 (SF-36) is a 36-item generic health status questionnaire 
that evaluates eight health concepts: physical function-
ing (ten items), role functioning: physical (four items), 
bodily pain (two items), general health (five items), vitality 
(four items), social functioning (two items), role function-
ing: emotional (three items), and mental health (five items). 
Scores were transformed linearly to scales of 0 to 100, 
with 0 and 100 assigned to the lowest and highest possible 
scores,   respectively, for all measures of these nine health 
components. Higher scores indicate better quality of life. 
Recently, two summary scores have been introduced to 
improve the interpretation of the SF-36, that is, the physical 
component score and the mental component score. These 
scores are standardized to have a mean of 50 and a standard 
deviation of 10 in normal populations.33 The use of the 
SF-36 has been validated in COPD.34 Suggested MCID 
levels (small, moderate and large) for the change over time, 
established by three expert panels of physicians are provided 
on the 8 scales of the SF-36.35 Another study suggested that 
a change of 5 points in the vitality component represents an 
MCID in this domain.36
statistical analysis
Differences in characteristics between patients who completed 
the program and those who dropped out were tested with an 
independent sample t-test for continuous data and with Chi-
square for categorical data. P-values ,0.05 were considered 
to be statistically significant. Measurements before and after 
completing the program were compared with a paired sample 
t-test. To explore determinants of the change (∆) in health 
status, univariate correlations were first calculated between 
predictor variables and ∆6MWDT and ∆SGRQ. Independent 
variables that correlated with ∆health status at the P , 0.05 
level were included in subsequent multivariate analyses. In 
addition, binary logistic regression analysis (likelihood-ratio 
change) was performed to identify predictors of responders. 
For this analysis, the 6MWDT and SGRQ were chosen 
because they represent two important domains of outcome, 
that is, exercise performance and quality of life. Moreover, 
these outcome measures have established levels of MCID. 
Patients with a response exceeding the MCID were marked as 
responders, whereas patients with a response lower than the 
MCID were judged non-responders. The Statistical Package 
for the Social Sciences (SPSS; SPSS Inc. Chicago, Illinois 
version 18.0) was used for all statistical tests.
Results
Patient characteristics
Between June 2006 and June 2010, 437 patients with COPD 
entered the program; 307 inpatients and 130 outpatients. 
During the course of the program, 48 patients dropped out 
(11%). Twenty-one patients dropped out because of medical 
reasons other than COPD, with hospitalization in four of 
these patients. Another 13 patients dropped out because of 
COPD exacerbations, with hospitalization in 11 of these 13 
patients. Eleven patients prematurely ended the rehabilitation 
program due to non-adherence. Two patients died during the 
program because of non-COPD-related causes. Slightly more 
patients in the dropout group were inpatients (79% vs 69%). 
This difference was not significant. Baseline characteristics 
of the completers and dropouts are presented in Table 1. 
Dropouts had significantly higher MRC dyspnea scores, a 
higher resting arterial carbon dioxide tension, poorer exercise 
performance, and a higher BODE index. Significantly more International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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Table 1 Baseline characteristics of the completers and dropouts on the pulmonary rehabilitation program
Completers (n = 389) Dropouts (n = 48) P-value
Age, years 61 ± 9 63 ± 9 ns
gender, male:female 205:184 26:22 ns
MRC 3.6 ± 0.9 4.0 ± 1.0 ,0.05
BMI 26.1 ± 5.6 25.6 ± 6.5 ns
hbCO 1.6 ± 1.1 2.2 ± 1.6 ,0.05
BODe index 4.6 ± 2.0 5.4 ± 2.1 ,0.05
% users of chronic oxygen 17% 42% ,0.001
# exacerbations 5.2 ± 4.7 5.2 ± 3.2 ns
# hospitalization 1.7 ± 2.4 2.3 ± 2.5 ns
Pulmonary function
FeV1, L (% pred) 1.08 ± 0.50 (41 ± 17) 1.08 ± 0.50 (41 ± 17) ns
IVC, L (% pred) 3.268 ± 0.97 (95 ± 19) 3.11 ± 1.00 (91 ± 22) ns
Tiffeneau, % 34 ± 12 32 ± 11 ns
TLC, L (% pred) 7.02 ± 1.58 (122 ± 19) 7.10 ± 1.65 (121 ± 21) ns
FRC, L. (% pred) 4.79 ± 1.43 (156 ± 40) 4.95 ± 1.42 (160 ± 43) ns
RV, L (% pred) 3.77 ± 1.18 (178 ± 54) 4.00 ± 1.28 (184 ± 62) ns
DLco, mmoL/min/kPa (% pred) 3.76 ± 1.52 (45 ± 16) 3.558 ± 1.60 (43 ± 18) ns
PaO2 at rest, kPa 8.9 ± 1.2 8.5 ± 1.1 ns
PaCO2 at rest, kPa 5.3 ± 0.8 5.6 ± 0.9 ,0.05
Exercise performance
Wmax, Watt (% pred) 44 ± 19 (33 ± 19) 35 ± 24 (27 ± 14) ,0.05
6MWDT (% pred) 366 ± 104 (57 ± 15) 321 ± 102 (51 ± 16) ,0.01
CWR cycle test 4.7 ± 3.2 4.3 ± 2.5 ns
Quality of life
sgRQ total score 66 ± 12 67 ± 12 ns
sF-36-PCs 31 ± 79 31 ± 6 ns
sF-36-MCs 42 ± 12 42 ± 12 ns
Notes: Data are presented as mean ± sD or n (%), unless otherwise indicated.
Abbreviations: MRC, Medical Research Council dyspnea scale; BMI, body mass index, BODE, body-mass index, airflow obstruction, dyspnea, and exercise capacity;   
FeV1, forced expiratory volume in 1 second; % pred, % predicted; L, liter; IVC, inspiratory vital capacity; TLC, total lung capacity; FRC, functional residual capacity; RV, residual 
volume; DLco, carbon monoxide transfer factor; PaO2, arterial oxygen tension; PaCO2, arterial carbon dioxide tension; Wmax, maximal power output on cycle ergometer; 
6MWDT, 6 minute walking distance test; CWR, constant work rate; sgRQ, st george’s Respiratory Questionnaire; sF-36-PCs, summary physical component score on the 
Medical Outcomes Study Short-Form Survey, version 2 (SF-36); SF-36-MCS, Summary mental component score on the SF-36; ns, non-significant.
patients in the dropout group had an HbCO .2.5% (P = 0.04), 
odds ratio 2.16 [1.02–4.57] or were on chronic oxygen 
(P , 0.001), odds ratio 3.37 [1.80–6.33]. The frequency of 
moderate to severe exacerbations, requiring treatment with 
oral corticosteroids and/or antibiotics, in the year preceding 
participation in the PR, did not differ between both groups. 
Severe exacerbations requiring hospitalization tended to be 
higher in patients who dropped out (2.3 ± 2.5 vs 1.7 ± 2.3), 
but did not reach the level of significance (P = 0.10). No 
significant differences were found in age, body mass index, 
gender, pulmonary function, or quality of life.
Figure 1 shows some clinical phenotyping characteristics of 
the completers with respect to severity of airway obstruction, 
BODE index, MRC dyspnea score, and exacerbation frequency. 
Of the patients completing the rehabilitation, 76% have GOLD 
stages of III or IV , and 92% have an MRC dyspnea score of $3. 
The average BODE index for the   completers is 4.6 ± 2.0 with 
47% in quartile 3 or 4. Forty-five percent of the completers had 
had five exacerbations or more in the year preceding PR.
Characteristics of the patients completing the PR with 
respect to exercise performance are provided in Figure 2. 
Eight patients (2%) were only able to cycle unloaded and 
not capable of tolerating any load at all, not less than 
137 patients (35%) had a Wmax between 5 and 25 Watt. The 
high impact of quality of life is illustrated by an average 
SGRQ total score of 66 ± 12.
Changes in health-status measurements
Changes in measures of health status after 12 weeks of pulmo-
nary rehabilitation are summarized in Table 2. All measures 
of muscle performance, exercise performance, and quality of 
life improved statistically significantly (P , 0.001).
Quadriceps muscle strength and maximal inspiratory 
pressures improved on average by 21% and 13%, respectively. International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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With respect to exercise performance, 214 patients (55%) 
were identified as responders on the constant work rate cycle 
test whereas 265 patients (68%) were responders on the 
6MWDT. Quality of life measured with the SGRQ showed 
a clinically meaningful improvement in 290 patients (75%). 
The observed changes in SGRQ ranged from a very marked 
deterioration (an increase of $12 points) in eight patients 
(2%) to a very marked improvement (a decrease of $12 
points) in 206 patients (53%).
Predictors of improvement in health 
status
Significant univariate correlation coefficients were found 
between ∆6MWDT and baseline values of forced expiratory 
volume in 1 second % predicted (0.24), Tiffeneau (0.28), 
functional residual capacity % predicted (−0.22), monoxide 
transfer factor % predicted (0.13), quadriceps force (QF) 
% predicted (−0.13), maximal ventilation during exercise 
% predicted (−0.13), SGRQ total score (0.15), body mass 
index (0.24), and baseline 6MWDT (−0.23). Furthermore, 
significant univariate correlation coefficients were found 
between ∆SGRQ total score and baseline values of MRC 
dyspnea score (0.15 forced expiratory volume in 1 second % 
predicted (0.10), monoxide transfer factor % predicted (0.13), 
Wmax (−0.18), VO2peak (−0.22), 6MWDT (−0.12), body mass 
index (−0.16), and baseline SGRQ total score (−0.30).
Stepwise multiple regression analysis revealed the 
following independent predictors for ∆6MWDT, baseline 
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Abbreviations: GOLD, Global Initiative for Chronic Obstructive Lung Disease; MRC, Medical Research Council dyspnea scale; BODE, body-mass index, airflow obstruction, 
dyspnea, and exercise capacity.
<15 15–30
SGRQ total score (% maximal)
%
 
p
a
t
i
e
n
t
s
%
 
p
a
t
i
e
n
t
s
%
 
p
a
t
i
e
n
t
s
Maximal power output (watt) 6-minute walking distance (meters)
30–45 45–60 60–75 >75
<50
0
5
10
15
20
25
30
35
0
10
20
30
0
10
20
30
40
50–60 60–70 70–80 >80
<200 200–300 400–500 300–400 >500
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values of: (1) Tiffeneau (r = 0.28); (2) 6MWDT (r = 0.38); 
and (3) VO2peak (r = 0.44) in total explaining 19% of the 
variance (∆6MWDT = 66 + 0.97 × Tiffeneau − 0.23 × 
baseline 6MWDT + 41.2 × VO2peak). Independent   predictors 
of ∆SGRQ total score appeared to be baseline values 
of: (1) SGRQ (r = 0.32), (2) VO2peak (r = 0.41), and (3) 
MRC dyspnea score (r = 0.44) in total explaining 19% of 
the variance (∆SGRQ = 16 − 0.48 × baseline SGRQ − 8.2 × 
VO2peak + 2.7 × baseline MRC dyspnea score). Stepwise 
binary logistic regression analysis revealed that baseline 
6MWDT was the only significant predictor for ∆6MWDT. 
By the same method, baseline SGRQ and VO2peak were 
selected as predictors for ∆SGRQ.
Discussion
The main finding of the present study is that statistically 
significant and clinically relevant improvements were 
observed in health status after an intensive pulmonary 
rehabilitation program, in a COPD population with a severely 
impaired health status either expressed as HRQL or as 
health-care utilization. Further, a small part of the variance 
of change in health-status measurements could be predicted 
on the basis of baseline patient characteristics.
Characteristics of referred patients
Based on the position of our pulmonary rehabilitation center 
in the chain of care for people with COPD in The Netherlands, 
a very significant impact was, as expected, observed of the 
disease on different aspects of health status, except for pulmo-
nary function impairment. The average severity of the airway 
obstruction observed in this study (FEV1 = 41% predicted) is 
in line with the severity reported in many clinical trials on PR, 
in which typically patients with moderate to severe COPD 
are included.4 A more profound impact was observed on 
exercise performance and an even greater impact on quality 
of life. For instance, the SGRQ total score at baseline of 66 
Table 2 Changes in measures of health status after 12 weeks of pulmonary rehabilitation
Variable Pre-PR Post-PR 95% CI of the change P-value
Muscle performance
Quadriceps force, nm 262 ± 99 316 ± 101 +53 [48−58] ,0.001
PImax, cm h2O   72 ± 24   81 ± 22 +16 [15−18] ,0.001
Exercise performance
CWR cycle endurance, seconds 285 ± 197 526 ± 305 +241 [212−271] ,0.001
6MWDT, meters 366 ± 104 418 ± 107 +52 [45−58] ,0.001
Quality of life
CRQ
  Dyspnea  3.2 ± 0.9  4.9 ± 1.1 +1.7 [1.6−1.8] ,0.001
  Fatigue  3.4 ± 1.1  5.0 ± 1.1 +1.6 [1.5−1.7] ,0.001
  emotions  4.2 ± 1.2  5.2 ± 1.1 +1.1 [1.0−1.2] ,0.001
  Mastery  4.4 ± 1.4  5.6 ± 1.1 +1.2 [1.1−1.3] ,0.001
sgRQ
  symptoms   65 ± 19   52 ± 21 −13 [−11−16] ,0.001
  Activities   83 ± 11   72 ± 18 −10 [−9−12] ,0.001
  Impact   56 ± 15   40 ± 18 −16 [−14−18] ,0.001
  Total   66 ± 12   52 ± 16 −14 [−15−18] ,0.001
sF-36
  Physical functioning   23 ± 18   44 ± 22 +21 [19−23] ,0.001
  Role functioning: physical     9 ± 21   35 ± 36 +26 [22−29] ,0.001
  Bodily pain   63 ± 27   69 ± 25 +6 [3−9] ,0.001
  general health   26 ± 15   35 ± 18 +9 [7−11] ,0.001
  Vitality   38 ± 17   57 ± 18 +19 [17−21] ,0.001
  social functioning   48 ± 26   67 ± 22 +19 [16−22] ,0.001
  Role functioning: emotional   40 ± 42   68 ± 39 +27 [22−32] ,0.001
  Mental health   58 ± 21   71 ± 18 +13 [11−15] ,0.001
  PCs   31 ± 7   36 ± 9 +5 [4−6] ,0.001
  MCs   42 ± 12   50 ± 10 +8 [7−9] ,0.001
Notes: Data are presented as mean ± sD or n (%), unless otherwise indicated.
Abbreviations: PR, pulmonary rehabilitation; CI, confidence interval; Nm, newton meter; PImax, maximal inspiratory pressure; CWR, constant work rate; 6MWDT, 6 minute 
walking distance test; CRQ, Chronic Respiratory Questionnaire; sgRQ, st george’s Respiratory Questionnaire; sF-36, Medical Outcomes study short-Form survey, version 
2; PCs, summary physical component score on the sF-36; MCs, summary mental component score on the sF-36.International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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in the present study is 10 points higher than the average of 
the six studies using the SGRQ in the Cochrane systematic 
review on pulmonary rehabilitation.4
A likely explanation for the high impact on HRQL in 
the present study is the high number of exacerbations and 
hospitalizations in the year preceding referral. Health-care 
utilization and quality of life have been found to be inversely 
related.37 The level of health-care utilization in our population 
is even higher than that described in a recent study which 
included COPD patients with chronic hypercapnic failure 
(5.2 exacerbations/year and 1.7 hospitalizations/year in our 
population, compared with 3 exacerbations/year and 0−2 
hospitalizations/year).38
Characteristics of dropouts
A relatively small portion of the participants (11%) dropped 
out during the course of the rehabilitation. In the literature, 
dropout rates of as high as 31% have been reported.39 One 
likely explanation for this success was the possibility of 
offering the program on an inpatient basis to patients with 
significant exercise intolerance. Difficulties with transpor-
tation have been well recognized as a factor interfering 
with attendance at pulmonary rehabilitation, especially in 
patients impacted more severely by the disease.40 Those 
who dropped out did so primarily due to medical reasons 
other than COPD and, secondly, due to COPD exacerba-
tions that require hospitalization. Analysis of the charac-
teristics reveals that these patients were impacted by the 
disease more severely at entry, as the BODE index was 
significantly higher. There was greater pulmonary gas 
exchange disturbance, with a higher arterial carbon dioxide 
tension at rest. These patients were also more likely to be 
users of chronic oxygen. Differences in the aforementioned 
characteristics were present despite similarities in values 
of spirometry, static lung volumes, and diffusing capac-
ity. The predictive validity of the factors associated with 
prematurely ending the rehabilitation program, however, 
is low. Consequently, it is not possible to reliably predict 
candidates that are likely to complete or vice versa drop 
out at entry of the program.
Pre- to post-rehabilitation changes  
in measures of health status
The pre- to post-rehabilitation changes in all dimensions 
of health status are significant from both the statistical 
and clinical points of view. The pre- to post-rehabilitation 
difference exceeds the MCID by two- to threefold. For 
instance, the fall in total score of the SGRQ is on average 
14 points. This means that the average change in HRQL 
following our interdisciplinary program is very high.41 
Further examination of the individual responses shows that 
75% of the completers had a fall in SGRQ total score higher 
than the MCID of 4 points. This indicates an improvement 
in HRQL in a vast majority of those who completed the 
program.
A relevant question to ask now is to what this success 
can be attributed. By definition PR is a multidisciplinary, 
individually tailored intervention based on a thorough 
assessment.6 At the start of the program, all patients 
  participated in a 5 day assessment in which important domains 
potentially determining health status were reviewed.8 On the 
basis of this assessment, a multifaceted, individually tailored 
program was offered based on individual goals. The patients 
wrote these goals down in their personal rehabilitation file. 
One of the members of the rehabilitation team acted as case 
manager. Every 3 weeks, all patients had an individual ses-
sion with the case manager to evaluate the progress that had 
been made in obtaining the individual rehabilitation goals. 
Diversions from the desired response to the rehabilitation 
were recognized early, enabling adaptations to the program at 
an early stage of the rehabilitation. A comprehensive plan of 
care, including evaluation and revision during rehabilitation, 
may be considered key elements in maximizing the potential 
of patients with chronic respiratory conditions.42
The intensity of the program is probably another feature 
that contributes to the results of the program in this seriously 
affected subgroup of patients, since a “dose−response” 
relationship has been found for pulmonary rehabilitation.6 
Our 12-week, 5-days-per-week program is certainly much 
more intensive than the average program described in 
RCTs on pulmonary rehabilitation. The “average program” 
typically has a design of 8−12 weeks, with only three 
sessions per week of a maximum of 2−3 hours each. Many 
of the patients participating in our intensive program had 
failed to improve their health on such a program and were 
therefore referred to our tertiary center. The majority of 
these patients benefited from the more intense program that 
we offered. We also believe that the high level of health-
care utilization in our population might have prevented 
a less comprehensive rehabilitation program from being 
successful.
Predictors of success
In the present study we were also interested in finding 
predictors of successful outcome of our comprehensive 
and intense program. Based on accepted MCIDs for the International Journal of COPD 2011:6 submit your manuscript | www.dovepress.com
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6MWDT and SGRQ, we were able to identify responders on 
exercise performance and HRQL. Responses to rehabilitation 
turned out to be difficult to predict on the basis of a single 
set of baseline characteristics or on the basis of a set of 
multiple independent variables. Explained variances did 
not exceed 19%. This result complies with earlier studies on 
the prediction of outcome of PR and suggests that patients 
impacted most severely by the disease benefit most from our 
comprehensive rehabilitation.40
An explanation for the weak predictability of the response 
may be the significant heterogeneity of clinical presentation 
and disease progression in COPD.43 Important determinants 
of symptoms, functional impairment, and quality of life may 
vary significantly between patients.44 Given this variation, it 
may be well argued that an accurate prediction of individual 
responses to rehabilitation, on the basis of a single or arbitrary 
set of baseline characteristics is unlikely. Expectations 
of an accurate prediction of response to rehabilitation on 
an individual level may be reduced further, if we realize 
that PR is an individually tailored intervention, comprised 
of multiple components. Accurate prediction of response 
to a variable treatment in a strong heterogeneous target 
population can hardly be expected. Consequently, the 2001 
recommendation from the British Thoracic Society statement 
on pulmonary rehabilitation is still valid, that is, every patient 
with persistent symptoms might be considered for pulmonary 
rehabilitation.45
Limitations of this study
It is known that comorbidities frequently accompany COPD 
and interfere with health status.46 This is also true for many 
of the patients referred to our center. However, we have not 
registered the number and/or type of comorbidities in our 
research charts systematically. This may have resulted in an 
inability to evaluate statistically the impact of comorbidi-
ties on health status and the extent to which this may have 
affected the change in health status following rehabilitation. 
In a recent study on the efficacy of rehabilitation in COPD, 
it was found that the effects of PR on the 6MWDT were 
inversely but weakly related to the presence of osteopo-
rosis.47 No association was found between the presence of 
comorbidities and change in SGRQ. Interestingly, the best 
predictors of improvement of a particular outcome were 
also baseline values in this study. These findings suggest 
that exclusion of patients for PR should not be based on the 
presence of comorbidities, but rather the indication for and 
allocation to different types of comprehensive PR programs 
should be based on the impact of the disease on overall health 
status. Instruments that evaluate this impact on overall health 
status have been developed and are currently undergoing 
validation.11
The lack of control group in this study obviously does 
not allow firm conclusions to be made about the effective-
ness of our program. However, the goal of our study was 
not to add evidence to the literature on the effectiveness 
of PR. We agree with the authors of the latest Cochrane 
systematic review on PR that there are already strong argu-
ments that PR is beneficial and that there is no need for 
additional RCTs.4 Our intention was to gain an impression 
of the acute outcomes of our interdisciplinary program in 
a population with a severely impaired health status and a 
very high level of health-care utilization that might prevent 
a less intense program from being successful.
Conclusions
In summary, the present study provides data that COPD 
patients may substantially benefit from rehabilitation 
in a tertiary pulmonary rehabilitation center, despite a 
severely impaired health status and high level of health-
care utilization, in which prior treatment in primary and 
secondary care have failed to improve health status. 
Individual rehabilitation responses cannot be reliably 
predicted on the basis of baseline characteristics. 
Consequently, no firm conclusions can be drawn from this 
study with respect to the selection of candidates that could 
be deemed eligible for this rehabilitation program.
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Appendix
Content of the comprehensive 
pulmonary rehabilitation program
I group modules
Physical fitness
•  General exercise reconditioning; three classes per week, 
¾ hour each
•  Peripheral muscle training; three classes per week, ¾ 
hour each
•  Interactive educational class on the importance of an 
active lifestyle; one class of 1 hour
Physical activity in daily life
•  Training in self-management with respect to improving 
physical behavior; four classes per week, 1 hour each
•  Swimming; one class per week, ¾ hour each
nutrition
•  Interactive educational session on the importance of a 
healthy diet; one class of 1 hour
Dyspnea management
•  Training in relaxation techniques; one class per week, 
1 hour each
•  Training in body awareness; one class per week, 1 hour 
each
•  Training in breathing retraining at rest and during differ-
ent types of exercise; one class per week, 1 hour each
•  Interactive educational classes on exercise limiting 
  factors; two classes, 1 hour each
exacerbation management
•  Interactive educational session on exacerbations of chronic 
obstructive pulmonary disease; one class of 1 hour
•  Educational conversations with respiratory nurse on 
self-management of exacerbations of chronic obstructive 
pulmonary disease; three sessions, ½ hour each
Functional training
•  Training in general principles of energy conservation, 
work simplification strategies, activity configuration 
for planning daily activities, exploration of avocations, 
hobby or other meaningful leisure activities, and assess-
ment of adaptations needed to allow patient to continue 
to participate; two classes per week, 1 hour each
Medication
•  Consults with a pulmonologist, once per week, ¼ hour 
each. Extra visits on indication
•  Interactive educational class on medication management; 
one class of 1 hour
•  Interactive educational class on medication inhalation 
technique; one class of 1 hour
social system
•  Pre-rehabilitation educational class on the concept of 
rehabilitation. In this session one or two close relatives 
are invited to participate; one class of 2 hours
•  Interactive educational class on the interaction between a 
person with a chronic disease and his/her social system. 
In this session one or two close relatives are invited to 
participate; one class of 1 hour
•  Participation of partner or other close relative on one 
representative day
Coping
•  Consult with case manager on the progress with regards to 
individual rehabilitation goals; four sessions, ½ hour each
•  Interactive educational class on the influence of psychological 
factors on symptoms, disability, and quality of life in people 
with a chronic lung condition. In this session one or two close 
relatives are invited to participate; one class of 1 hour
Illness perceptions and cognitions
•  Interactive educational classes on cognitions with respect 
to behaviors interfering with appropriate adaptation to a 
chronic lung condition; two classes of 1 hour
•  Creative therapy in which illness perceptions and beliefs 
are explored nonverbally; one class per week of 1 hour
II Individual modules
On indication, additional modules were added to the aforemen-
tioned group modules. These modules were provided on an 
individual basis and include outdoor physical fitness training, 
counseling by a dietician, inspiratory muscle   training, training 
in mucus evacuation techniques, consults with a respiratory 
nurse whenever the need was insufficiently met with the group 
sessions, consults with an occupational therapist, consults with 
a creative therapist for assistance with hobby development, 
consults with a psychologist, consults with a social worker.